Sign in Subscribe
Diseases

Chronic Alcohol Intake Disrupts Cytochrome P450 Enzyme Activity in Alcoholic Fatty Liver Disease

Strategic Insights

— 1 min read

Research conducted by scientists at Anhui Medical University has shed new light on the long-term effects of alcohol on the liver. The study, published in the journal Frontiers in Chemistry, found that prolonged ethanol exposure disrupts the activity and expression of key enzymes, including CYP2E1, CYP2D6, and CYP3A1, which play a crucial role in metabolizing alcohol and other compounds.

Key Takeaways:

  • The study used a rat model to examine the influence of prolonged ethanol exposure on CYP450 activity and expression in alcoholic fatty liver disease (AFLD).
  • Significant alterations were identified in the expression and activity of CYP2E1, CYP2D6, and CYP3A1, which were associated with increased lipid accumulation and oxidative stress in the liver.
  • The expression of P-glycoprotein (P-gp) was elevated, suggesting that chronic alcohol intake may impact drug transport and excretion.
  • The findings provide new insights into the molecular mechanisms of AFLD and highlight the potential of CYP450 modulation as a therapeutic target.
  • The study's results lay the groundwork for developing personalized therapeutic strategies to improve outcomes for patients with AFLD.
  • Researchers identified Qian Zhu, Ling Fang, Cheng Huang, and Jun Li as co-authors on the study.
  • The study's lead author was Xuefeng Xie, a researcher at Anhui Medical University.

Statistics:

  • 13:1509785 is the reference number for the study published in Frontiers in Chemistry.
  • Frontiers in Chemistry is a peer-reviewed journal that can be contacted at: Frontiers Media Sa, Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland.
  • The study's publication date is listed as 13 June 2025 in the source material.
  • The journal Frontiers in Chemistry has a publisher contact information of: Frontiers Media Sa, Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland.

Sources:

  • Chronic alcohol intake disrupts cytochrome P450 enzyme activity in alcoholic fatty liver disease: insights into metabolic alterations and therapeutic targets. Frontiers in Chemistry, 2025;13:1509785.
  • Xuefeng Xie, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, People's Republic of China.

Read more